Xcout IntelSign inSubscribe

Cerapedics competitors & alternatives

Medical DevicesUnited States

The 12 closest competitors and alternatives to Cerapedics among medical devices companies — ranked by similarity to what Cerapedics actually does, not by market-cap band.

12Competitors listed

Subscribe to see Cerapedics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

About Cerapedics

Cerapedics Inc. is headquartered in Westminster, Colorado, United States, and develops orthopedic biologics and bone graft products.

Cerapedics at a glance

Cerapedics is a medical devices company headquartered in United States. Its most recent funding round raised $25M in February 2022. Xcout tracks 13 named people at Cerapedics, including Valeska Schroeder (Chief Executive Officer).

Cerapedics leadership

  • Valeska SchroederChief Executive Officer
  • Mani GopalChief Operating Officer
  • Martyn WebsterChief Financial Officer
  • Jeffrey G. MarxChief Scientific Officer
  • Nathan PhilippChief Commercial Officer
  • Kimberly BurkeGeneral Counsel

7 more named people on record for Cerapedics, with roles, board committees and tenure — see the full roster →

Cerapedics funding rounds

The 4 most recent:

DateRoundAmountInvestors
—$25M—
—$22M1 named
SEC Form D filing$11M—
SEC Form D filing$4M—

Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →

Top 12 Cerapedics competitors

Ranked by semantic similarity — how close each company is to Cerapedics by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.

MiMedx Group, IncMDXG · Medical DevicesMarietta, United States
64% matchPublic

Similar medical devices company

MiMedx Group, Inc. specializes in creating and supplying allografts derived from placental tissue, serving a diverse range of medical fields. The company employs its unique, patented PURION process to treat human placental tissues, a method crucial for manufacturing allografts that preserve the natural biological characteristics and essential regulatory proteins of the original tissue. This exclusive and patented processing technique incorporates both aseptic procedures and a final sterilization step, ensuring product safety and efficacy. Among its offerings is EpiFix, a semi-permeable membrane designed to act as a protective barrier, effectively treating persistent wounds such as diabetic foot ulcers, venous leg ulcers, and pressure sores. Another key product is AmnioFix, a protective, semi-permeable allograft made from dehydrated human amnion/chorion membrane, utilized to aid post-surgical recovery. EpiCord and AmnioCord, both derived from dehydrated human umbilical cord, function as allografts that foster a protective healing environment and are applied in both advanced wound care and surgical recovery contexts. AMNIOBURN is also a semi-permeable protective allograft specifically developed for managing partial and full-thickness burn injuries. Its flagship product, mdHACM, is a micronized, powdered version of AMNIOFIX. These products predominantly find use in healthcare sectors like wound management, burn treatment, surgical procedures, and non-operative sports medicine. Additionally, the company supplies allografts for dental uses to other manufacturers on an original equipment manufacturer (OEM) basis. Distribution of its products primarily occurs within the United States, facilitated by its own sales teams, independent agents, and various independent distributors. MiMedx Group, Inc.'s main office is located in Marietta, Georgia.

Market cap$704.9M
Employees808
MiMedx Group, Inc competitors & alternatives →
Orthofix Medical Inc.OFIX · Medical DevicesLewisville, United States
62% matchPublic

Similar medical devices company

Orthofix Medical Inc., founded in 1980 and headquartered in Lewisville, Texas, operates as a global medical technology company focusing on devices and biologics. Its reach extends across the United States, several European nations including Italy, Germany, France, and the United Kingdom, as well as Brazil and other international markets. The company's operations are divided into two main segments: Global Spine and Global Orthopedics. Within the Global Spine division, Orthofix is responsible for the development, production, and distribution of bone growth stimulators. These devices are designed to facilitate bone fusion and serve as a therapeutic intervention for fractures located outside the spine and in the limbs. This segment also creates and commercializes a range of motion preservation and fixation implant products utilized in spinal surgical procedures. Furthermore, it supplies physicians with various tissue forms and synthetic-based regenerative biologic solutions to address a wide spectrum of spinal and orthopedic conditions. The Global Orthopedics segment concentrates on the design, development, and commercialization of specialized orthopedic products. These offerings are essential for procedures involving fracture repair, the correction of deformities, and bone reconstruction. Orthofix distributes its products to a diverse clientele, including physicians, hospitals, outpatient surgery centers, and integrated health delivery systems. This is achieved through a comprehensive sales network that includes its own sales force, independent distributors, and both employed and external sales representatives. The company, previously known as Orthofix International N.V., officially changed its name to Orthofix Medical Inc. in July 2018.

Market cap$375.1M
Employees1,616
Orthofix Medical Inc. competitors & alternatives →
Xtant Medical Holdings, Inc.XTNT · Medical DevicesBelgrade, United States
66% matchPublic

Similar medical devices company

Xtant Medical Holdings, Inc., a company based in Belgrade, Montana, specializes in the development, production, and distribution of advanced regenerative medicine products and medical devices. The firm primarily serves orthopedic and neurological surgeons both within the United States and globally. Its comprehensive product portfolio is categorized into several key areas: 1. Biomaterial Offerings: This category includes products like OsteoSponge, which provides a natural structural support for cellular growth and introduces vital bone-forming proteins to aid the healing process. OsteoSponge SC is specifically designed to repair bone defects in the subchondral area of joints. Other items are OsteoSelect DBM Putty, fostering osteoinductive bone regeneration, and OsteoSelect PLUS DBM Putty, which functions as a bone void filler and graft substitute for procedures involving the pelvis, extremities, and posterolateral spine. Additionally, the line features OsteoFactor, containing diverse proteins and peptides that facilitate bone formation and remodeling, along with OsteoWrap and OsteoVive Plus, a cellular bone matrix enriched with growth factors. 2. Allograft Technologies: Under the 3Demin brand, Xtant Medical provides a range of allografts (human bone grafts) engineered to maximize both osteoconductivity and osteoinductive capabilities. This includes specialized sports allografts used for repairing anterior and posterior cruciate ligaments, ACL reconstruction, and meniscal repairs. They also offer milled spinal allografts, where cortical bone is precisely shaped to specific dimensions, as well as traditional allografts applicable across numerous medical disciplines such such as orthopedics, neurology, podiatry, oral/maxillofacial surgery, genitourinary, and plastic/reconstructive surgery. 3. Spinal Fixation and Fusion Systems: The company furnishes a variety of sophisticated spinal devices. These include the Certex spinal fixation system, Spider cervical plating, Axle interspinous fusion, Silex Sacroiliac joint fusion, the Xpress minimally invasive pedicle screw system, and Fortex Pedicle screw systems. Further systems encompass Calix, for use in cervical and thoracolumbar regions, the Axle-X interspinous fusion system, Irix-C for cervical integrated fusion, and the Irix-A Lumbar integrated fusion system. The company underwent a name change in July 2015, transitioning from its former identity as Bacterin International Holdings, Inc. to Xtant Medical Holdings, Inc.

Market cap$61.7M
Employees217
Xtant Medical Holdings, Inc. competitors & alternatives →

Analyze another company

Search any company we track to see its competitive set.

Or describe a company

Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.

See the full profile of Cerapedics and its market

Funding, investors, tech stack, hiring signals, leadership and corporate events — for Cerapedicsand every competitor above — in one live dashboard.

Subscribe to Xcout Intel →